Sponsor or institution
Clinical trials and research at The Affiliated Hospital Of Guizhou Medical University
As of November 12, 2026, Find a Trial lists 5 clinical trials run by The Affiliated Hospital Of Guizhou Medical University that are recruiting, in China. By phase: Phase 1/2 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Oral paclitaxel with anti-HER2 therapy in HER2-positive breast cancer before surgery | Phase 1/2 | Guiyang, Guizhou | Recruiting | Jul 31, 2026 |
| Oral paclitaxel in triple-negative breast cancer before main chemotherapy | Phase 1/2 | Guiyang, Guizhou | Recruiting | Jul 31, 2026 |
| Individualized mRNA cancer vaccine for advanced solid tumors | Early Phase 1 | Guiyang, China/Guizhou | Recruiting | Jul 11, 2024 |
| Using intrathecal nicardipine to treat vasospasm after aneurysmal subarachnoid hemorrhage | — | Hefei, Anhui and 27 other locations | Recruiting | Mar 26, 2024 |
| Analyzing treatment options for brain hemorrhage | — | Guiyang, Guizhou | Recruiting | Sep 21, 2022 |
All recruiting trials (5)
-
Oral paclitaxel with anti-HER2 therapy in HER2-positive breast cancer before surgery
This trial tests a paclitaxel oral solution given with trastuzumab and pertuzumab to see if a safe dose can be found for women with HER2-positive breast cancer before they have surgery.
-
Oral paclitaxel in triple-negative breast cancer before main chemotherapy
This trial tests whether giving an oral paclitaxel dose-6 in combination with standard epirubicin and cyclophosphamide can be tolerated in women with triple-negative breast cancer before surgery.
-
Individualized mRNA cancer vaccine for advanced solid tumors
This study is testing a personalized mRNA cancer vaccine to see if it can help people with advanced solid tumors feel better when combined with another treatment.
-
Using intrathecal nicardipine to treat vasospasm after aneurysmal subarachnoid hemorrhage
This study is testing if giving nicardipine directly into the spine can help patients with vasospasm after a brain bleed feel better compared to regular treatment.
-
Analyzing treatment options for brain hemorrhage
This study is trying to see how the shape of a brain bleed affects its growth and how different treatments can help patients with cerebral hemorrhage.
Quick answers
How many clinical trials run by The Affiliated Hospital Of Guizhou Medical University are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.